The Lisinopril Tablets, cataloged under National Stock Number 6505-01-428-2320, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Exelan Pharmaceuticals Inc Div Exelan Pharmaceuticals. Government technical data includes 4 specifications, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 3 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-428-2320 |
| Primary Part Number | NDC76282-0417-01 |
| Item Name | Lisinopril Tablets |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Exelan Pharmaceuticals Inc Div Exelan Pharmaceuticals |
| Status | ACTIVE |
| Primary Container Content Quantity | 100.000 TABLETS |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | BOTTLE |
| Active Medicament Medicinal Strength | 2.500 MILLIGRAMS LISINOPRIL ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC76282-0417-01 PRIMARY | Exelan Pharmaceuticals Inc Div Exelan Pharmaceuticals (USA) |
| Reference | Meaning |
|---|---|
| 96-0105 | 5/1 Secondary reference U.S. Government activity |
| ZESTRIL | 5/9 Secondary reference Astrazeneca Lp |
| NDC00310-0135-11 | 3/9 Design control — primary reference Astrazeneca Lp |
NSN 6505-01-428-2320 is a Lisinopril Tablets, manufactured by Exelan Pharmaceuticals Inc Div Exelan Pharmaceuticals, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-428-2320 has 1 manufacturer part number on file: NDC76282-0417-01 (Exelan Pharmaceuticals Inc Div Exelan Pharmaceuticals).
Key specifications for NDC76282-0417-01: Primary Container Content Quantity: 100.000 TABLETS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: BOTTLE; Part Name Assigned by Controlling Agency: LISINOPRIL TABLETS USP 2.5ML 100S. 4 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.